Works matching IS 13454676 AND DT 2019 AND VI 86 AND IP 3


Results: 8
    1
    2
    3
    4

    Multicenter Observational Study of Fulvestrant 500 mg in Postmenopausal Japanese Women with Estrogen Receptor-Positive Advanced or Recurrent Breast Cancer after Prior Endocrine Treatment (SBCCSG29 Study).

    Published in:
    Journal of Nippon Medical School, 2019, v. 86, n. 3, p. 165, doi. 10.1272/jnms.JNMS.2019_86-305
    By:
    • Kei Kimizuka;
    • Kenichi Inoue;
    • Shigenori E. Nagai;
    • Tsuyoshi Saito;
    • Satoko Nakano;
    • Kazushige Futsuhara;
    • Hirofumi Yamada;
    • Shiori Kaneko;
    • Takashi Sakurai;
    • Satoshi Hata;
    • Masafumi Kurosumi
    Publication type:
    Article
    5
    6
    7
    8